Evans Dwight L, Charney Dennis S, Lewis Lydia, Golden Robert N, Gorman Jack M, Krishnan K Ranga Rama, Nemeroff Charles B, Bremner J Douglas, Carney Robert M, Coyne James C, Delong Mahlon R, Frasure-Smith Nancy, Glassman Alexander H, Gold Philip W, Grant Igor, Gwyther Lisa, Ironson Gail, Johnson Robert L, Kanner Andres M, Katon Wayne J, Kaufmann Peter G, Keefe Francis J, Ketter Terence, Laughren Thomas P, Leserman Jane, Lyketsos Constantine G, McDonald William M, McEwen Bruce S, Miller Andrew H, Musselman Dominique, O'Connor Christopher, Petitto John M, Pollock Bruce G, Robinson Robert G, Roose Steven P, Rowland Julia, Sheline Yvette, Sheps David S, Simon Gregory, Spiegel David, Stunkard Albert, Sunderland Trey, Tibbits Paul, Valvo William J
School of Medicine, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA 19104, USA.
Biol Psychiatry. 2005 Aug 1;58(3):175-89. doi: 10.1016/j.biopsych.2005.05.001.
The purpose of this review is to assess the relationship between mood disorders and development, course, and associated morbidity and mortality of selected medical illnesses, review evidence for treatment, and determine needs in clinical practice and research.
Data were culled from the 2002 Depression and Bipolar Support Alliance Conference proceedings and a literature review addressing prevalence, risk factors, diagnosis, and treatment. This review also considered the experience of primary and specialty care providers, policy analysts, and patient advocates. The review and recommendations reflect the expert opinion of the authors.
STUDY SELECTION/DATA EXTRACTION: Reviews of epidemiology and mechanistic studies were included, as were open-label and randomized, controlled trials on treatment of depression in patients with medical comorbidities. Data on study design, population, and results were extracted for review of evidence that includes tables of prevalence and pharmacological treatment. The effect of depression and bipolar disorder on selected medical comorbidities was assessed, and recommendations for practice, research, and policy were developed.
A growing body of evidence suggests that biological mechanisms underlie a bidirectional link between mood disorders and many medical illnesses. In addition, there is evidence to suggest that mood disorders affect the course of medical illnesses. Further prospective studies are warranted.
本综述旨在评估情绪障碍与特定内科疾病的发生、病程以及相关发病率和死亡率之间的关系,回顾治疗证据,并确定临床实践和研究中的需求。
数据取自2002年抑郁与双相情感障碍支持联盟会议记录以及一篇关于患病率、危险因素、诊断和治疗的文献综述。本综述还考虑了初级和专科护理提供者、政策分析师以及患者权益倡导者的经验。该综述及建议反映了作者的专家意见。
研究选择/数据提取:纳入了流行病学和机制研究的综述,以及关于合并内科疾病患者抑郁症治疗的开放标签和随机对照试验。提取了关于研究设计、人群和结果的数据,以审查包括患病率表和药物治疗在内的证据。评估了抑郁症和双相情感障碍对特定内科合并症的影响,并制定了实践、研究和政策建议。
越来越多的证据表明,生物学机制是情绪障碍与许多内科疾病之间双向联系的基础。此外,有证据表明情绪障碍会影响内科疾病的病程。有必要进行进一步的前瞻性研究。